Flecainide is a class IC Na+ channel and RyR2 blocking drug with antiarrhythmic actions and is used clinically to treat atrial fibrillation, supraventricular tachycardia and CPVT. Here, RYR2 is linked to catecholaminergic polymorphic ventricular tachycardia.